Avoid ice directly on skin, instead wrapping it in a cloth
Meta-analyses of these and other studies have demonstrated: Reductions in total cholesterol typically in the range of 15% from baseline, varying by agent and population Decreases in LDL cholesterol ranging from 17%, generally more modest than dedicated lipid-lowering therapies Reductions in triglycerides of 515%, with greater effects often seen in those with higher baseline levels Variable effects on HDL cholesterol , with small increases (1-2%) or neutral effects reported The magnitude of lipid improvements appears to correlate with the degree of weight loss achieved, suggesting that metabolic benefits may be partially mediated through adiposity reduction
doi: 10.3389/fendo.2018.00754 Received 31 October 2018 Accepted 27 November 2018 Published 04 January 2019 Volume 9 - 2018 Edited by Maximilian Bielohuby, Sanofi, France Reviewed by Yoshio Fujitani, Gunma University, Japan
Phase 2 orforglipron data demonstrated 14.7% body weight reduction at 45mg without food or water requirements, and the addressable patient expansion is estimated to grow the anti-obesity medication market by 180 million new prescription patients between 2027 and 2032
The choice depends on whether glucose control or cardiovascular risk reduction is the higher priority for your specific situation
You can absolutely express a preference
